![Heather Preston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 254 778 $ au 31/08/2026
Dr. Heather E.
Preston, MD, is an Independent Non-Executive Director at Aligos Therapeutics, Inc., an Independent Non-Executive Director at Oxford Nanopore Technologies Plc, a Senior Advisor at Pivotal Bioventure Partners Investment Advisor LLC, an Independent Non-Executive Director at Oxford Biomedica Plc, an Independent Director at Entasis Therapeutics Holdings, Inc., an Independent Director at Entasis Therapeutics, Inc., a General Partner at Oxonian Ventures and a Non-Executive Chairman at Harness Therapeutics Ltd. She is on the Board of Directors at Aligos Therapeutics, Inc., Oxford Nanopore Technologies Plc, Oxford Science Enterprises PLC, Oxford Biomedica Plc, Entasis Therapeutics Holdings, Inc., Entasis Therapeutics, Inc., Azura Ophthalmics Ltd., Invenra, Inc., Fine Arts Museums of San Francisco and St. Luke'S School.
Dr. Preston was previously employed as an Independent Director by Akouos, Inc., an Independent Director by Karuna Therapeutics, Inc., an Independent Director by Fusion Pharmaceuticals, Inc., an Independent Director by Otonomy, Inc., an Independent Director by Albireo Pharma, Inc., a Managing Director by Tarrant Capital IP LLC, a Partner by TPG Biotech, an Associate by J.P.
Morgan Partners LLC, an Engagement Manager by McKinsey & Co., Inc., a Senior Advisor by Nan Fung Life Sciences, and an Entrepreneur-in-Residence by NEA Management Co. LLC.
She also served on the board at Avalyn Pharma, Inc., Alder Biopharmaceuticals, Inc., Virobay, Inc., Albireo AB, Albireo Ltd., Anaborex, Inc., Aptalis Pharma Canada ULC, Aptalis Pharma LLC, Conventus Orthopaedics, Inc., Elevation Pharmaceuticals, Inc., Unchained Labs LLC and Viral Logic Systems Technology Corp.
She received her undergraduate degree from St Bartholomew's Hospital Medical College and a doctorate degree from the University of Oxford.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC 0,03% | 31/12/2025 | 35 862 ( 0,03% ) | 254 778 $ | 31/08/2026 |
| 25/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 07/08/2024 |
| OXFORD NANOPORE TECHNOLOGIES PLC | Directeur/Membre du Conseil | 19/12/2023 |
| OXFORD BIOMEDICA PLC | Directeur/Membre du Conseil | 15/03/2018 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Directeur/Membre du Conseil | 01/08/2017 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Directeur/Membre du Conseil | 01/08/2017 |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Directeur/Membre du Conseil | 01/01/2021 |
Azura Ophthalmics Pty Ltd.
 Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Designs ophthalmic keratolytics | Directeur/Membre du Conseil | - |
Oxford Angel Fund
 Oxford Angel Fund Investment ManagersFinance Oxonian Ventures invests in companies located in the United States. The firm targets companies operating in the field of the educational technology service sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Invenra, Inc.
 Invenra, Inc. Pharmaceuticals: MajorHealth Technology Develops technology platform for biological drugs | Directeur/Membre du Conseil | - |
| ░░░░ ░░░░ ░░░░░░░ ░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 38 |
|---|---|
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Anaborex, Inc.
 Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | Health Services |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Health Technology |
Oxford Nanopore Technologies Plc
 Oxford Nanopore Technologies Plc Electronic Equipment/InstrumentsElectronic Technology Develops instruments for electronic detection and analysis of molecules | Electronic Technology |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology | Health Technology |
Conventus Orthopaedics, Inc.
 Conventus Orthopaedics, Inc. Medical/Nursing ServicesHealth Services Provides orthopedic surgical solutions, including sterile-packaged implants and instrument kits for foot, ankle and extremity surgeries | Health Services |
Invenra, Inc.
Invenra, Inc. Pharmaceuticals: MajorHealth Technology Develops technology platform for biological drugs | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology | Finance |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory disorders | Health Technology |
Fine Arts Museums of San Francisco
 Fine Arts Museums of San Francisco Other Consumer ServicesConsumer Services Operates museums | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Elevation Pharmaceuticals, Inc.
 Elevation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures aerosol drug products | Health Technology |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Tarrant Capital IP LLC
 Tarrant Capital IP LLC Investment ManagersFinance Operates as an alternative asset management firm | Finance |
St Bartholomew's Hospital Medical College
 St Bartholomew's Hospital Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unchained Labs
 Unchained Labs Medical SpecialtiesHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research | Health Technology |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Finance |
St. Luke'S School
 St. Luke'S School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Finance |
TPG Biotech
 TPG Biotech Investment ManagersFinance TPG Biotech seeks investment opportunities in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, medical technology, and healthcare services. It provides financing for early and later stage capital requirements. | Finance |
Azura Ophthalmics Pty Ltd.
Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Designs ophthalmic keratolytics | Health Technology |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences invests in companies located across the globe. The firm focuses on life sciences sectors such as health technology, biotechnology, pharmaceuticals, electrical instruments and medical services. It provides financing for seed, early and growth stage capital requirements. | Finance |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
Oxford Angel Fund
Oxford Angel Fund Investment ManagersFinance Oxonian Ventures invests in companies located in the United States. The firm targets companies operating in the field of the educational technology service sector. It provides financing for early stage capital requirements. | Finance |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
Transine Therapeutics Ltd.
 Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
